Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China
SHANGHAI & TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Investments Singapore Pte Ltd (TPIS), a subsidiary of…
2 years ago
China Buy Now Pay Later Report 2024: 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis, Business Model and Demographics – Forecasts to 2029 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs…
2 years ago
Capcom Announces Million-Dollar Grand Prize for Capcom Pro Tour 2024!
Aims to further invigorate the esports fighting game scene following company’s highest-ever prize pool in…
2 years ago
Radware Drives New Revenue Streams for Managed Security Service Providers
Enables MSSPs to provide industry-leading security services, while reducing total cost of ownership MAHWAH, New…
2 years ago
Visa and the GSMA Mobile for Development Foundation Launch Digital Finance for All Initiative
The five-year initiative aims to advance digital financial inclusion for 20 million individuals and businesses…
2 years ago
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Continued rapid global growth with record total revenues of $634 million in fourth quarter and…
2 years ago
Wipro and Nokia Launch Joint 5G Private Wireless Solution to Speed up Enterprise Digital Transformation
HELSINKI & BENGALURU, India--(BUSINESS WIRE)--$WIPRO #5G--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading…
2 years ago
VinBrain welcomes new board and advisory board members, Dr. Gregory Moore, and Jonathan T. Fried
Leaders in Healthcare Technology, AI and Governance Join VinBrain’s Ranks HANOI, VIETNAM - Media OutReach…
2 years ago
VinFast officially breaks ground on its integrated electric vehicle facility in India
THOOTHUKUDI, TAMIL NADU - Media OutReach Newswire - 26 February 2024 - VinFast, Vietnam's leading…
2 years ago
BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Recommendation based on results of three Phase 3 clinical trials demonstrating benefit of tislelizumab as…
2 years ago